Why Are Doximity Shares Gaining Today?

After two consecutive below-expectations quarterly results, Doximity Inc (NYSE:DOCS) shares surged on Friday after the company reported better-than-expected Q2 FY23 financial…
  • After two consecutive below-expectations quarterly results, Doximity Inc (NYSE:DOCS) shares surged on Friday after the company reported better-than-expected Q2 FY23 financial results.
  • Doximity’s Q2 sales climbed 29% Y/Y to $102.19 million, beating the consensus of $100.12 million, with non-GAAP diluted net income per share of $0.17, versus $0.19 a year ago better than the consensus of $0.15.
  • The company sees Q3 FY23 sales of $110.7-$111.7 million versus the consensus of $114.9 million.
  • Doximity’s board also authorized a share buyback of up to $70 million.
  • Analyst Reactions:
    • Wells Fargo Maintains Overweight on Doximity, Raises Price Target to $44
    • Evercore ISI raised the company’s price target to $32 from $28.
  • Price Action: DOCS shares are up 26.2% at $33.23 on the last check Friday.
Total
0
Shares
Related Posts
Read More

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases between 2013 and 2017, scientists have found that monkeypox transmission in a remote part of the Democratic Republic of the Congo is much higher than previously thought.

AEMD